COMPANY
Clinical Phase 1
Keywords: oncology immuno-oncology Non Small Cell Lung Cancer Pancreatic Carcinoma Colorectal Cancer Colorectal Adenocarcinoma Pancreatic Adenocarcinoma Lung Cancer Ovarian Cancer Breast Cancer Head and Neck Squamous Cell Carcinoma Prostate Cancer Bladder Cancer CLSP-5282 CLSP-1025
Location: Cambridge, MA · source · Oct 14, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1: A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) source ↗
- Trial start Phase 1: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation source ↗
Upcoming milestones
- 2027-12 (ESTIMATED) · Phase 1 · A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation · NCT06778863
- 2029-05 (ESTIMATED) · Phase 1 · A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) · NCT07650357
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT07650357 | A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) | Phase 1 | Not yet recruiting | 2026-07 | 2029-05 (estimated) |
| NCT06778863 | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation | Phase 1 | Recruiting | Feb 28, 2025 | 2027-12 (estimated) |
